"Founded in 2008 Chicago Clinical Research Institute, Inc. (CCRII) is a multi-specialty dedicated research facility conducting phase II to phase IV clinical trials. CCRII has a combined 50 years of clinical research experience and has conducted more than 250 clinical research trials in the therapeutic areas of Diabetes Mellitus Type II, Hypertension, Hyperlipidemia, Chronic Kidney Disease, Cardiovascular Disease, Osteoarthritis, Rheumatoid Arthritis, Pain Management, Neuropathy, Gynecology, Male Health, Ophthalmology, and Oncology"

During the past decade, IMA Clinical Research - Chicago conducted 4 clinical trials. In the 10-year time frame, 4 clinical trials started and 0 clinical trials were completed, i.e. on average, 0% percent of trials that started reached the finish line to date. In the past 5 years, 4 clinical trials started and 0 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

According to Clinical.Site data, the most researched conditions in "IMA Clinical Research - Chicago" are "Acute Pain" (1 trials), "Alzheimer Disease" (1 trials), "Atherosclerotic Cardiovascular Disease" (1 trials), "Back Muscle Spasm" (1 trials) and "Back Pain" (1 trials). Many other conditions were trialed in "IMA Clinical Research - Chicago" in a lesser frequency.

Most popular intervention types in "IMA Clinical Research - Chicago" are "Drug" (4 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (4 trials), "Donanemab" (1 trials), "Obicetrapib" (1 trials), "Tirzepatide" (1 trials) and "Tolperisone Hydrochloride" (1 trials). Other intervention names were less common.

The vast majority of trials in "IMA Clinical Research - Chicago" are 4 trials for "All" genders.

Currently, there are NaN active trials in "IMA Clinical Research - Chicago". undefined are not yet recruiting, 3 are recruiting, undefined are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 1 completed trials in IMA Clinical Research - Chicago, undefined suspended trials, and undefined terminated clinical trials to date.

Out of the total trials that were conducted in IMA Clinical Research - Chicago, 0 "Phase 1" clinical trials were conducted, 0 "Phase 2" clinical trials and 4 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 0 trials that are defined as “Not Applicable".